Kawanishi, Japan

Toshiyuki Tomoo

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Daiichi Sankyo Company, Limited. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Toshiyuki Tomoo. Retrieved from https://idiyas.com/inventor/toshiyuki-tomoo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Toshiyuki Tomoo: Innovator in Pharmaceutical Chemistry

Introduction

Toshiyuki Tomoo is a notable inventor based in Kawanishi, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds with specific biological activities. His work has implications for various therapeutic applications.

Latest Patents

Toshiyuki Tomoo holds 1 patent related to a compound, or its salt, or a solvate thereof, which exhibits cPLA2-inhibiting activity. This patent includes a pharmaceutical composition, cPLA2 inhibitor, and inhibitors of various lipid mediator production containing the same as active ingredients. The formula outlined in his patent represents a significant advancement in the field.

Career Highlights

Toshiyuki Tomoo is associated with Daiichi Sankyo Company, Limited, a leading global pharmaceutical company. His role at the company has allowed him to engage in innovative research and development, contributing to the advancement of medical science.

Collaborations

He has collaborated with notable colleagues, including Yasuhiro Hayashi and Takashi Nakatsuka. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries.

Conclusion

Toshiyuki Tomoo's contributions to pharmaceutical chemistry and his innovative patent work highlight his importance in the field. His ongoing research and collaborations continue to pave the way for future advancements in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…